Skip to content
HowShorted

Taysha Gene Therapies, Inc. short interest in 2026

In 2026, Taysha Gene Therapies, Inc.'s disclosed short interest ran from 20.75% of shares outstanding on 15 Jan 2026 to 15.78% on 15 Sep 2026, a change of -4.97 percentage points. The year's high was 20.75% on 15 Jan 2026 and its low 12.54% on 29 May 2026, averaging 15.64% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 23.57 days on 27 Feb 2026. Full history: Taysha Gene Therapies, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Taysha Gene Therapies, Inc. in 2026

2026 in figures

Start of year
20.75% (15 Jan 2026)
End of year
15.78% (15 Sep 2026)
Change
-4.97 pp
High
20.75% (15 Jan 2026)
Low
12.54% (29 May 2026)
Average
15.64%
Highest days to cover
23.57 (27 Feb 2026)
SEC filings marked
6

Every report in 2026

Taysha Gene Therapies, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202620.75%20.13
30 Jan 202620.33%20.49
13 Feb 202617.87%21.59
27 Feb 202618.14%23.57
13 Mar 202616.94%15.86
31 Mar 202614.72%13.0810-K filed, results (8-K)
15 Apr 202613.55%14.24
30 Apr 202613.94%14.00
15 May 202612.78%15.0910-Q filed, results (8-K)
29 May 202612.54%16.37
15 Jun 202613.48%15.38
30 Jun 202614.41%8.06
15 Jul 202615.77%13.34
31 Jul 202616.25%19.00
14 Aug 202614.34%17.4210-Q filed, results (8-K)
31 Aug 202614.36%19.40
15 Sep 202615.78%18.78

See also: Taysha Gene Therapies, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.